This clearly indicates that S100A10, and not annexin A2, is the actual regulator of plasmin-mediated fibrinolysis in these cells and that PML-RARα-mediated S100A10 up-regulation is likely to be responsible for the bleeding symptoms in APL patients. This evidence concerns the gene S100A10 and acute promyelocytic leukemia.